Our previous study also showed that Skp2 stabilizes Mcl-1 and thus confers radioresistance to colorectal cancer [45], suggesting that targeting Mcl-1 could be an extremely promising strategy for cancer treatment. The gene discussed is SKP2; the disease is cancer.